Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
Stanford Gertz, a director at Strawberry Fields REIT, Inc. (NASDAQ: STRW), purchased 392 shares on March 13, 2026, at $12.89 per share for a total of $5,052, increasing his direct holding to 819 shares. The transaction was disclosed in a Form 4 filing with the SEC. Separately, the company declared a $0.16 per share cash dividend for Q1 2026 and dis…
Roland Thomas Kelly, Chief Legal Officer and General Counsel of Velocity Financial, Inc. (NYSE: VEL), sold 14,840 shares of the company's common stock across two trades on March 30 and March 31, 2026, receiving $267,771 in total proceeds. The disposals occurred amid a backdrop of robust fourth-quarter fiscal 2025 results and divergent valuation ass…
SoftVest, LP purchased 68,467 units of Cross Timbers Royalty Trust (NYSE: CRT) on March 27, 2026, paying a weighted average price of $10.24 per unit for a total of $701,102. Following the acquisition the firm directly holds 697,851 units. The move coincides with a recent 16% one-week gain in CRT shares and a near 40% year-to-date rise, though third…
Karen A. Foster, Chief Quality and Operations at BioLife Solutions Inc (NASDAQ: BLFS), sold 2,577 shares on March 23, 2026, under a Rule 10b5-1 trading plan. The transaction, executed at a weighted average price of $19.17, totaled $49,401 and leaves Foster with 108,758 shares held directly. The sale occurs while BLFS is trading close to its 52-week…
Asana Inc.'s Chief Financial Officer, Megji Aziz, sold 30,650 Class A shares on March 27, 2026, receiving $6.1033 per share for a total of $187,066. The transaction was carried out under a pre-established Rule 10b5-1 plan and follows recent company results and multiple analyst price-target reductions. Aziz continues to hold 224,549 shares after the…
Rapport Therapeutics Chief Operating Officer Cheryl Gault sold 10,000 shares of the company's common stock on March 30, 2026, in two transactions totaling $281,857 under a Rule 10b5-1 trading plan. The company recently reported fiscal 2025 results and Phase IIa data for RAP-219 in focal seizures, and plans to begin two Phase 3 studies in the second…
Director Lu Hongbo bought 75,000 shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) on March 31, 2026, at $20.00 per share, a $1.5 million purchase executed through an underwritten public offering. The acquisition increases Lu's indirect holdings to 422,968 shares. The company concurrently announced a $200 million convertible note offering and a 5 mill…
Macy's Executive Vice President and Chief Human Resources Officer Danielle L. Kirgan sold 5,161 shares of Macy's common stock on March 30, 2026 for $91,515 after exercising 11,256 restricted stock units on March 28. The stock trades at $18.10, and third-party analysis places the company near a fair value of $17.74 with a low P/E of 7.8. Macy's repo…
Rezolute Chief Financial Officer Daron Evans purchased 10,000 common shares on March 30, 2026, acquiring stock worth $28,500 at $2.85 per share, increasing his direct holdings to 414,462 shares. The buy comes amid a roughly 70% six-month decline in the stock and ongoing regulatory engagement with the FDA over the company’s ersodetug program for con…
Martine Rothblatt, chairperson and CEO of United Therapeutics (UTHR), sold $5.6 million of company stock on March 30, 2026 under a pre-arranged 10b5-1 trading plan and exercised options to acquire additional shares the same day. The transactions come amid a wave of analyst updates following positive Phase 3 TETON-1 results for the company’s Tyvaso …
Epsilon Energy Ltd. CEO Jason Stabell bought 20,000 common shares between March 27 and March 31, 2026, spending $124,180 across three transactions reported on a Form 4 filing. The purchases come after a quarterly earnings beat and amid a substantial year-to-date share-price gain; the stock traded at $6.16 at the close, down 0.65%.
Macy’s Chairman and CEO Antony Spring disposed of 27,451 shares of common stock on March 30, 2026, generating roughly $486,799 at prices between $17.5450 and $17.8850. A Form 4 filing shows Spring also exercised options to acquire 53,152 shares on March 28, 2026, shares that were obtained via conversion of restricted stock units. The insider moves …
Chidozie Ugwumba, who holds a roughly ten percent stake in Clene Inc. (NASDAQ: CLNN) through Symbiosis II, LLC, sold 100,997 shares of the company's common stock across three transactions between March 27 and March 31, 2026, generating about $494,012 in proceeds. The trades occurred at prices between $4.75 and $5.10 per share. After the sales, Ugwu…
Range Resources CEO Dennis Degner sold 15,000 shares on March 30, 2026, while three days earlier he received 76,334 shares issued net of taxes under a March 2023 PSU grant. The company also reported stronger-than-expected Q4 2025 results and raised its quarterly dividend, as analysts maintained hold ratings with adjusted price targets.
Macy's senior vice president and Controller Paul Griscom sold 433 shares of Macy's common stock on March 30, 2026, for about $7,683 to satisfy tax-withholding obligations tied to the vesting of restricted shares. The filings also show Griscom exercised options for 1,501 shares on March 28 tied to Restricted Stock Units granted in 2024. Macy's recen…
Erin McDowell, senior vice president and general counsel of Range Resources (NYSE: RRC), sold 8,250 shares on March 27, 2026, at $48.00 per share, for a total of $396,000. After the sale McDowell retains 84,451 shares directly and holds additional indirect and performance-based equity. Range reported fourth-quarter 2025 results that beat analysts' …
Olivier Bron, chief executive of Bloomingdale’s, reported the sale of 3,051 Macy’s shares on March 30, 2026, netting $54,132 at a weighted average price of $17.7424. The transaction followed an option exercise and RSU vesting on March 28 that added 7,504 shares at no cost. Macy’s recent quarterly results beat expectations, but fiscal 2026 guidance …
Macy’s Executive Vice President, Chief Legal Officer and Corporate Secretary Tracy M. Preston sold 2,736 shares of Macy’s common stock on March 30, 2026, for approximately $48,536. The sale followed Preston’s exercise of 7,504 options on March 28. The retailer reported stronger-than-expected fourth-quarter fiscal 2025 results, while several analyst…
Thomas J. Herzfeld, Chairman of the Advisor at Herzfeld Credit Income Fund, acquired 2,974 shares of the fund on March 27, 2026, paying $15.50 per share for a total of $46,097. The purchase raised his direct holdings to 193,638 shares amid a recent board-approved 10-for-1 reverse stock split and a near-90% dividend yield reported for the fund.
Andrew Callos, Executive Vice President and Chief Commercial Officer of Cytokinetics INC (NASDAQ: CYTK), sold 3,639 shares on March 31, 2026 at $65.00 per share, generating proceeds of $236,535. The transaction comes as the stock trades close to its 52-week high and after a strong one-year return. Several research firms have recently increased thei…
Nicole S White, Chief Manufacturing Officer at Assembly Biosciences (ASMB), completed a minor sale of 197 shares on March 30, 2026 to satisfy tax withholding requirements while receiving a grant of 26,000 restricted stock units the prior day. The RSUs vest in four equal annual installments beginning March 29, 2027, contingent on continuous service.…
Jeanette M. Bjorkquist, who serves as Principal Financial Officer and Principal Accounting Officer at Assembly Biosciences (ASMB), sold 328 shares on March 30, 2026 to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units. The transactions, executed in two tranches at prices between $26.65 and $27.49 per s…
Stas R. Wolak, Executive Vice President and Chief Retail Banking Officer at First Mid Bancshares, Inc. (NASDAQ:FMBH), sold 430 shares of company common stock on February 20, 2026, generating $18,778 at $43.67 per share. The transaction comes as the shares trade close to a 52-week high and after First Mid closed the acquisition of Two Rivers Financi…
Director Shandell Szabo sold 11,731 shares of Magnolia Oil & Gas Corp Class A common stock on March 30, 2026, for $375,169 at a weighted average price of $31.981. The transaction left Szabo with 14,304 shares outstanding. The insider trade comes amid Magnolia's fourth-quarter 2025 results that narrowly missed consensus on both EPS and revenue and a…
Michael Wayne Domino Jr., President of the DTR Division at Drilling Tools International Corp (NASDAQ: DTI), sold 3,169 shares on March 31, 2026, at $4.00 per share for proceeds of $12,676. The transaction occurred while DTI shares traded close to a 52-week high of $4.38 after a 62% gain over the past year. Domino maintains a substantial equity stak…
